Investigation of the Optimal Cocktailed Probiotics for Decolonization of Vancomycin-resistant Enterococci in Human Gut

计划入组 100 人 · 首次发布于 2019 年 1 月 30 日

Theraworx Bath Wipes Versus Standard Bath Wipes in the Reduction of Vancomycin-Resistant Enterococci

计划入组 159 人 · 首次发布于 2014 年 9 月 16 日

The Epidemiology of Infection With Vancomycin-Resistant Enterococci

首次发布于 2001 年 7 月 5 日

Vancomycin(Firvanq, Vancocin)

C₆₆H₇₅Cl₂N₉O₂₄ · Rx

Gentamicin/Vancomycin

Desvancosaminyl vancomycin

C₅₉H₆₂Cl₂N₈O₂₂

Acurx Pharmaceuticals

United States

Cardiff Oncology

United States

Armata Pharmaceuticals

United States

Theriva Biologics Presents Phase 1b/2a Safety Data for SYN-004 in Hematopoietic Cell Transplant Recipients at ESCMID Global

Immuron Advances Multi-Drug Pipeline with FDA Submissions and Clinical Milestones on Track for 2025

Immuron Reports Record Sales Growth and Advances Multiple Clinical Programs for Infectious Disease Treatments